X-123613410-C-T
Position:
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 1P and 6B. PP2BP4_ModerateBS2
The NM_001081550.2(THOC2):c.4666G>A(p.Gly1556Ser) variant causes a missense change. The variant allele was found at a frequency of 0.0000175 in 1,202,814 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 6 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000054 ( 0 hom., 0 hem., cov: 22)
Exomes 𝑓: 0.000014 ( 0 hom. 6 hem. )
Consequence
THOC2
NM_001081550.2 missense
NM_001081550.2 missense
Scores
4
13
Clinical Significance
Conservation
PhyloP100: 3.79
Genes affected
THOC2 (HGNC:19073): (THO complex subunit 2) The TREX multiprotein complex binds specifically to spliced mRNAs to facilitate mRNA export. The protein encoded by this gene is a member of the THO complex, a subset of the TREX complex. The encoded protein interacts with the THOC1 protein.[provided by RefSeq, Jun 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -5 ACMG points.
PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), THOC2. . Gene score misZ 5.5258 (greater than the threshold 3.09). GenCC has associacion of gene with X-linked intellectual disability-short stature-overweight syndrome.
BP4
Computational evidence support a benign effect (MetaRNN=0.13933074).
BS2
High Hemizygotes in GnomAdExome4 at 6 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
THOC2 | NM_001081550.2 | c.4666G>A | p.Gly1556Ser | missense_variant | 36/39 | ENST00000245838.13 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
THOC2 | ENST00000245838.13 | c.4666G>A | p.Gly1556Ser | missense_variant | 36/39 | 5 | NM_001081550.2 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000541 AC: 6AN: 110945Hom.: 0 Cov.: 22 AF XY: 0.00 AC XY: 0AN XY: 33317
GnomAD3 genomes
AF:
AC:
6
AN:
110945
Hom.:
Cov.:
22
AF XY:
AC XY:
0
AN XY:
33317
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000283 AC: 5AN: 176589Hom.: 0 AF XY: 0.0000316 AC XY: 2AN XY: 63381
GnomAD3 exomes
AF:
AC:
5
AN:
176589
Hom.:
AF XY:
AC XY:
2
AN XY:
63381
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000137 AC: 15AN: 1091869Hom.: 0 Cov.: 29 AF XY: 0.0000167 AC XY: 6AN XY: 358719
GnomAD4 exome
AF:
AC:
15
AN:
1091869
Hom.:
Cov.:
29
AF XY:
AC XY:
6
AN XY:
358719
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000541 AC: 6AN: 110945Hom.: 0 Cov.: 22 AF XY: 0.00 AC XY: 0AN XY: 33317
GnomAD4 genome
AF:
AC:
6
AN:
110945
Hom.:
Cov.:
22
AF XY:
AC XY:
0
AN XY:
33317
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ExAC
AF:
AC:
3
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 07, 2024 | The c.4666G>A (p.G1556S) alteration is located in exon 36 (coding exon 36) of the THOC2 gene. This alteration results from a G to A substitution at nucleotide position 4666, causing the glycine (G) at amino acid position 1556 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T;.;.;.;T;T
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D;D;D;.;D
M_CAP
Benign
D
MetaRNN
Benign
T;T;T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
L;.;.;.;L;.
MutationTaster
Benign
D;D;D
PrimateAI
Uncertain
T
PROVEAN
Benign
N;.;D;D;N;N
REVEL
Benign
Sift
Benign
T;.;D;T;T;T
Sift4G
Benign
T;T;T;T;T;T
Polyphen
P;.;.;.;P;.
Vest4
MutPred
Gain of phosphorylation at G1556 (P = 2e-04);.;.;.;Gain of phosphorylation at G1556 (P = 2e-04);.;
MVP
MPC
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at